Country focus: China & APAC’s growing medical needs bring opportunities and challenges
pharmaphorum
JUNE 8, 2021
All these factors will support the growth of in-house R&D-driven pharmaceutical companies and bring more innovative drugs to Asian markets.”. Chemotherapy still accounted for 72.6% Mei says that oncology is one of the key region-specific unmet medical needs Antengene is hoping to address with innovative drugs.
105 
Let's personalize your content